Skip to main content


OneOncology Leads Community Practices in Innovation, Pathway Development

April 30, 2019








At the Community Oncology Alliance (COA) Annual Meeting (April 4-5, 2019; Orlando, FL), Journal of Clinical Pathways sat down with three of the leaders of OneOncology – a new partnership of independent community oncology practices that is physician-driven and utilizes a unified platform to enable physicians to care for patients through the entire course of care. OneOncology was started with  three leading community oncology practices: Tennessee Oncology, West Cancer Center, and New York Cancer & Blood Specialists.

Tracy L Bahl, president and chief executive officer of OneOncology, Jeff Vacirca, MD, FACP, chief executive officer and managing partner of New York Cancer & Blood Specialists, and Robin Shah, chief development and marketing officer of OneOncology, provide the details of what makes OneOncology different than other leading community practice collaborations as well as how it is built to withstand hospital consolidation.

To read the podcast transcript, click here.


Back to Top